Redhill expands manufacturing for COVID-19 candidate by Lucy Parsons | Oct 14, 2020 | News | 0 Company signs deals with two specialist pharmaceutical manufacturers Read More
MHRA issues consent for RedHill Bioharma’s Yeliva trial by Selina McKee | Jun 30, 2020 | News | 0 The study will assess the potential of the drug in patients hospitalised with severe SARS-CoV-2 infection and pneumonia Read More